NanoViricides, Inc. (NNVC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

NanoViricides, Inc. (NNVC) is up 33.6% since the beginning of the year. At $2 per share, NNVC is trading 32.3% below its 52-week high of $2. Investors who bought $1,000 worth of NNVC shares 5 years ago would now be looking at an investment worth $403.

NanoViricides, Inc. (NNVC) has returned 33.63% so far this year and 2.72% over the past 12 months. Over the last ten years, NNVC has returned -27.30% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Oct 26, 2005, NNVC's average daily return is +0.18%, while the average monthly return is +3.82%. At this rate, an investment would double in approximately 1.5 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jan 2020 with a return of +567.7%, while the worst month was Sep 2019 at -51.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, NNVC closed higher 41% of trading days. The best single day was Sep 10, 2013 with a return of +153.7%, while the worst single day was Jan 22, 2020 at -55.1%.

NanoViricides, Inc. has an annualized alpha of 49.48%, beta of 0.44, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since October 27, 2005.

• This stock participated in 109.25% of S&P 500 Index downside but only 31.28% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.44 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NNVC ranks 45 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for NanoViricides, Inc. (NNVC) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the NanoViricides, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the NanoViricides, Inc. was 99.36%, occurring on Feb 5, 2026. The portfolio has not yet recovered.

The current NanoViricides, Inc. drawdown is 98.86%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of NanoViricides, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how NanoViricides, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.